These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 20718341)

  • 21. [Cloning and characterization of M1 gene of H3N2 subtype swine influenza virus].
    Guo L; Wang X; Liu Q; Shen Y; Qiu Y; Li X; Luo M; Ma Z
    Sheng Wu Gong Cheng Xue Bao; 2009 May; 25(5):672-8. PubMed ID: 19670634
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Production and diagnostic application of monoclonal antibodies against influenza virus H5.
    Yang M; Clavijo A; Graham J; Salo T; Hole K; Berhane Y
    J Virol Methods; 2009 Dec; 162(1-2):194-202. PubMed ID: 19699764
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prophylactic and therapeutic efficacy of a chimeric monoclonal antibody specific for H5 haemagglutinin against lethal H5N1 influenza.
    Prabhu N; Prabakaran M; Hongliang Q; He F; Ho HT; Qiang J; Goutama M; Lim AP; Hanson BJ; Kwang J
    Antivir Ther; 2009; 14(7):911-21. PubMed ID: 19918095
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Generation of monoclonal antibodies reactive against subtype specific conserved B-cell epitopes on haemagglutinin protein of influenza virus H5N1.
    Fiebig P; Shehata AA; Liebert UG
    Virus Res; 2015 Mar; 199():46-55. PubMed ID: 25599601
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cross-protection against influenza virus infection by intranasal administration of M2-based vaccine with chitosan as an adjuvant.
    Sui Z; Chen Q; Wu R; Zhang H; Zheng M; Wang H; Chen Z
    Arch Virol; 2010 Apr; 155(4):535-44. PubMed ID: 20195654
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human single-chain antibodies that neutralize homologous and heterologous strains and clades of influenza A virus subtype H5N1.
    Maneewatch S; Thanongsaksrikul J; Songserm T; Thueng-In K; Kulkeaw K; Thathaisong U; Srimanote P; Tongtawe P; Tapchaisri P; Chaicumpa W
    Antivir Ther; 2009; 14(2):221-30. PubMed ID: 19430097
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A live attenuated H1N1 M1 mutant provides broad cross-protection against influenza A viruses, including highly pathogenic A/Vietnam/1203/2004, in mice.
    Xie H; Liu TM; Lu X; Wu Z; Belser JA; Katz JM; Tumpey TM; Ye Z
    J Infect Dis; 2009 Dec; 200(12):1874-83. PubMed ID: 19909080
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effective small interfering RNAs targeting matrix and nucleocapsid protein gene inhibit influenza A virus replication in cells and mice.
    Zhou H; Jin M; Yu Z; Xu X; Peng Y; Wu H; Liu J; Liu H; Cao S; Chen H
    Antiviral Res; 2007 Nov; 76(2):186-93. PubMed ID: 17719657
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Preparation and characterization of monoclonal antibodies to rabies virus CVS-11 strain].
    Cao L; Li X; Zhang SF; Li LJ; Hu RL; Tang Q
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2009 Feb; 23(1):68-70. PubMed ID: 19799024
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detection of circulating Asian H5N1 viruses by a newly established monoclonal antibody.
    Du A; Daidoji T; Koma T; Ibrahim MS; Nakamura S; de Silva UC; Ueda M; Yang CS; Yasunaga T; Ikuta K; Nakaya T
    Biochem Biophys Res Commun; 2009 Jan; 378(2):197-202. PubMed ID: 19010309
    [TBL] [Abstract][Full Text] [Related]  

  • 31. H5N1 VLP vaccine induced protection in ferrets against lethal challenge with highly pathogenic H5N1 influenza viruses.
    Mahmood K; Bright RA; Mytle N; Carter DM; Crevar CJ; Achenbach JE; Heaton PM; Tumpey TM; Ross TM
    Vaccine; 2008 Oct; 26(42):5393-9. PubMed ID: 18706956
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of an influenza A H5N2 reassortant as a candidate for live-attenuated and inactivated vaccines against highly pathogenic H5N1 viruses with pandemic potential.
    Desheva JA; Lu XH; Rekstin AR; Rudenko LG; Swayne DE; Cox NJ; Katz JM; Klimov AI
    Vaccine; 2006 Nov; 24(47-48):6859-66. PubMed ID: 17050041
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protection against H1, H5, H6 and H9 influenza A infection with liposomal matrix 2 epitope vaccines.
    Ernst WA; Kim HJ; Tumpey TM; Jansen AD; Tai W; Cramer DV; Adler-Moore JP; Fujii G
    Vaccine; 2006 Jun; 24(24):5158-68. PubMed ID: 16713037
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antibodies and CD4(+) T-cells mediate cross-protection against H5N1 influenza virus infection in mice after vaccination with a low pathogenic H5N2 strain.
    Droebner K; Haasbach E; Fuchs C; Weinzierl AO; Stevanovic S; Büttner M; Planz O
    Vaccine; 2008 Dec; 26(52):6965-74. PubMed ID: 18848593
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vaccines with MF59 adjuvant expand the antibody repertoire to target protective sites of pandemic avian H5N1 influenza virus.
    Khurana S; Chearwae W; Castellino F; Manischewitz J; King LR; Honorkiewicz A; Rock MT; Edwards KM; Del Giudice G; Rappuoli R; Golding H
    Sci Transl Med; 2010 Jan; 2(15):15ra5. PubMed ID: 20371470
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Generating and characterizing monoclonal and polyclonal antibodies against avian H5N1 hemagglutinin protein.
    Wang SF; Chen KH; Thitithanyanont A; Yao L; Lee YM; Chan YJ; Liu SJ; Chong P; Liu WT; Huang JC; Chen YM
    Biochem Biophys Res Commun; 2009 May; 382(4):691-6. PubMed ID: 19327345
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Production and characterization of monoclonal antibodies against binary ethylenimine inactivated Nipah virus.
    Berhane Y; Berry JD; Ranadheera C; Marszal P; Nicolas B; Yuan X; Czub M; Weingartl H
    J Virol Methods; 2006 Mar; 132(1-2):59-68. PubMed ID: 16226320
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Recombinant expression of human influenza A virus nucleocapsid protein and its antigenicity analyses].
    Bao YH; Xin RL; Deng J; Wang F; Qian Y; Wu JX; Zhang T
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Jun; 22(3):208-10. PubMed ID: 19031705
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Establishment of hybridoma cell line secreting specific monoclonal antibodies against turnip mosaic virus and analysis of properties of the McAb.
    Yang F; Cai S; Xu L; Feng L
    Chin J Biotechnol; 1992; 8(4):247-54. PubMed ID: 1343828
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunization with plasmid DNA encoding influenza A virus nucleoprotein fused to a tissue plasminogen activator signal sequence elicits strong immune responses and protection against H5N1 challenge in mice.
    Luo M; Tao P; Li J; Zhou S; Guo D; Pan Z
    J Virol Methods; 2008 Dec; 154(1-2):121-7. PubMed ID: 18789973
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.